Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Txinno Bioscience

Explore full profile
Yongin-si, South KoreaFounded 2020Biotech & Life Sciences
Valuation $50–100M Last recorded · 2023
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Txinno Bioscience and the history behind them.

At a glance

Status
Operational
Founded
2020
Headquarters
Yongin-si, South Korea
Employees
12
Open positions
None listed
Dealroom signal
31.6/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b
Links
WebsiteLinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Mar 2023 $9.6M $38M Undisclosed —
SERIES B✓Equity / VC Dec 2022 $17M $66M Medytox Venture Investment · Daily Partners · Soliders Investment —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Txinno Bioscience website traffic

Latest recorded traffic for Txinno Bioscience is 3.2K monthly website visits, up 33.3% over the last three months. Txinno Bioscience's team declined 14.3% over the past year.

Latest monthly visits3.2K 3-month web change+33.3% 1-year team growth-14.3%
Monthly website visitsMay 2023–Jul 2026
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
ALTx TherapeuticsFirst-in-class precision oncology targeting immortal cancer cell pathways. Houghton and Wyton, United Kingdom Operational — $13M $50M
NK:IODeveloping technologies to improve cancer treatment London, United Kingdom Operational
Phlox TherapeuticsRNA-based gene therapies for genetic heart diseases Naarden, Netherlands Operational
ChemifyDigitizing chemistry by developing technology to convert chemical code into molecules and vice versa Glasgow, United Kingdom Operational
METiS TherapeuticsAI-driven platform for drug discovery and delivery Cambridge, United States Operational
Rarity BioscienceApplication: Rarity Safelock assay detects AML mutations Uppsala kommun, Sweden Operational
Eikonizo TherapeuticsDeveloping therapies to improve the treatment of human disease, specifically neurodegenerative diseases Cambridge, United States Operational
OncoLizeInjectable drug depots to treat tumors from the inside Maastricht, Netherlands Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Medytox Venture Investment
  • Daily Partners
  • Soliders Investment

Other known investors2 additional known investors

  • Company K Partners
  • Korea Advanced Institute of Science and Technology

Talent

Book a demo to see the people
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇰🇷 South Korea90.9%
🇺🇸 United States9.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Txinno Bioscience on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Txinno Bioscience’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.